Imagine a microscopic world inside each of your cells, where a constant balancing act determines life or death. This intricate dance dictates when to build, recycle, or halt the production of essential molecules. A critical player in this cellular choreography is folate metabolism, which provides the building blocks for DNA, RNA, and amino acids. But what happens when this delicate system goes awry? The consequences can range from developmental disorders to the dreaded C-word: cancer.
Now, a groundbreaking study from CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in collaboration with the University of Oxford, has unveiled an unexpected hero in this metabolic drama: the enzyme NUDT5. Their findings, published in Science, reveal that NUDT5 doesn't just help to switch off the production of purines (the essential components of DNA) – it does so in a way that defies our expectations.
A New Twist on an Old Player
Purines are the unsung heroes of our cells, crucial for constructing DNA and RNA, and for storing the energy that fuels our bodies. They can be salvaged from existing materials or manufactured from scratch through a process called de novo synthesis, which is a highly regulated and energy-intensive process.
Researchers delved into this control mechanism by examining cells with mutations in the MTHFD1 gene, a key player in the folate cycle. Defects in this pathway are linked to rare genetic diseases and can influence cancer risk. Using a combination of cutting-edge techniques, the team discovered that the protein NUDT5 interacts with another enzyme, PPAT, which kickstarts purine synthesis. When purine levels are high, NUDT5 steps in, binding to PPAT and effectively putting the brakes on purine production.
But here's where it gets controversial...
What's truly astonishing is that NUDT5 performs this function without relying on its known enzymatic activity, which involves breaking down nucleotide derivatives. Even when scientists chemically blocked or genetically disabled its catalytic site, the protein continued to regulate purine synthesis. Only when NUDT5 was completely removed did cells lose this crucial control mechanism.
Metabolic Control with Far-Reaching Implications
This discovery sheds new light on how cells sense and respond to changes in their metabolic environment. "NUDT5 has long been classified as an enzyme that hydrolyzes metabolites," says Stefan Kubicek, the study's senior author. "But our work reveals a completely different role - it acts as a structural regulator that determines whether the cell keeps producing purines or not."
And this is the part most people miss... This mechanism may also explain why some cancer cells become resistant to certain chemotherapy drugs. "Many chemotherapies, such as 6-thioguanine, work by mimicking purine molecules and blocking DNA synthesis," explains Tuan-Anh Nguyen, a co-first author of the study. "But we found that cells without functional NUDT5–PPAT interaction were less sensitive to these treatments, suggesting that mutations in NUDT5 could contribute to drug resistance in tumors." Similar findings from Ralph DeBerardinis’ laboratory, published in the same issue of Science, further support the critical role of NUDT5 in cancer drug sensitivity.
Furthermore, the research connects the dots between folate metabolism, purine synthesis, and diseases caused by MTHFD1 deficiency, a rare genetic disorder affecting immune and neurological development. "Because the folate and purine pathways are tightly linked, understanding this regulatory network could eventually inform new therapeutic approaches," adds Jung-Ming George Lin, another co-first author.
A Glimmer of Hope
Collaborators in Kilian Huber’s lab in Oxford have also developed a chemical degrader called dNUDT5, which can selectively eliminate NUDT5 from cells. This tool will allow scientists to study the pathway in more detail and may offer future possibilities for protecting healthy cells from chemotherapy side effects.
"Our findings highlight that enzymes not only can act via the chemical reactions they catalyze, but also through their structure," concludes Kubicek. "Sometimes, it’s the physical presence of a protein that makes the crucial difference."
What are your thoughts? Do you find it surprising that an enzyme can function in a way that doesn't rely on its catalytic activity? Could this new understanding of NUDT5 lead to more effective cancer treatments? Share your opinions in the comments below!
